Table 7.
Mechanism of carbapenem resistance in bacterial strains of carbapenemase-producing Enterobacterales (CP-CRE) in patients with or without concomitant SARS-CoV-2 (COVID-19) that were included in a retrospective case–control study that aimed to identify the strains of carbapenem-resistant Enterobacteriaceae and the risk factors associated with acquiring these infections.
| Mechanism of resistance of CP-CRE | Patients with COVID-19n = 38 | Patients without COVID-19n = 26 | Statistical analysisa |
|---|---|---|---|
| Total CP-CRE | 14 (36.84) | 2 (7.69) | P = 0.023 |
| CP-CRE (KPC) | 4 (10.53) | 0 (0.00) | – |
| CP-CRE (OXA-48) | 2 (5.26) | 0 (0.00) | – |
| CP-CRE (MBL) | 1 (2.63) | 2 (7.69) | – |
| CP-CRE (KPC/OXA-48) | 5 (13.16) | 0 (0.00) | – |
| CP-CRE (KPC/MBL) | 2 (5.26) | 0 (0.00) | – |
Data presented as n of patients (%).
aχ2-test.
KPC, Klebsiella pneumoniae carbapenemase; OXA-48, oxacillinase-48; MBL, metallo-β-lactamase.